Oscar D. Bustuoabad

594 total citations
34 papers, 475 citations indexed

About

Oscar D. Bustuoabad is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Oscar D. Bustuoabad has authored 34 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 12 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Oscar D. Bustuoabad's work include Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Cancer Research and Treatments (6 papers). Oscar D. Bustuoabad is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Cancer Research and Treatments (6 papers). Oscar D. Bustuoabad collaborates with scholars based in Argentina, United States and Netherlands. Oscar D. Bustuoabad's co-authors include Raúl A. Ruggiero, Christiane Dosne Pasqualini, R. Daniel Bonfil, Roberto P. Meiss, Paula Chiarella, María Clara Franco, Ana Llorens, Àngels Fabra, Fernando Benavides and Antònia Vinyals and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and British Journal of Cancer.

In The Last Decade

Oscar D. Bustuoabad

34 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oscar D. Bustuoabad Argentina 13 223 142 135 76 47 34 475
Raúl A. Ruggiero Argentina 14 260 1.2× 137 1.0× 207 1.5× 65 0.9× 44 0.9× 38 552
Marian Rocha Germany 12 167 0.7× 205 1.4× 321 2.4× 65 0.9× 27 0.6× 18 627
Caren Jayasinghe Germany 10 286 1.3× 204 1.4× 182 1.3× 138 1.8× 21 0.4× 16 510
Aizhi Zhao China 13 196 0.9× 297 2.1× 196 1.5× 53 0.7× 29 0.6× 23 633
Nicole C. Smits United States 14 99 0.4× 252 1.8× 109 0.8× 66 0.9× 42 0.9× 18 537
Kristen F. Meckel United States 4 327 1.5× 196 1.4× 522 3.9× 37 0.5× 46 1.0× 5 744
Alison Connor Canada 13 117 0.5× 285 2.0× 152 1.1× 109 1.4× 15 0.3× 17 550
Peter T.M. Moerkerk Netherlands 15 376 1.7× 463 3.3× 90 0.7× 161 2.1× 24 0.5× 23 950
Tiziana Tonini United States 11 229 1.0× 431 3.0× 58 0.4× 143 1.9× 17 0.4× 15 646

Countries citing papers authored by Oscar D. Bustuoabad

Since Specialization
Citations

This map shows the geographic impact of Oscar D. Bustuoabad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oscar D. Bustuoabad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oscar D. Bustuoabad more than expected).

Fields of papers citing papers by Oscar D. Bustuoabad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oscar D. Bustuoabad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oscar D. Bustuoabad. The network helps show where Oscar D. Bustuoabad may publish in the future.

Co-authorship network of co-authors of Oscar D. Bustuoabad

This figure shows the co-authorship network connecting the top 25 collaborators of Oscar D. Bustuoabad. A scholar is included among the top collaborators of Oscar D. Bustuoabad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oscar D. Bustuoabad. Oscar D. Bustuoabad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chiarella, Paula, Mónica Vermeulen, Roberto P. Meiss, et al.. (2018). Improvement of Antitumor Therapies Based on Vaccines and Immune-Checkpoint Inhibitors by Counteracting Tumor-Immunostimulation. Frontiers in Oncology. 8. 6–6. 5 indexed citations
3.
Ruggiero, Raúl A., Paula Chiarella, Martı́n A. Isturiz, et al.. (2011). Tyrosine Isomers Mediate the Classical Phenomenon of Concomitant Tumor Resistance. Cancer Research. 71(22). 7113–7124. 30 indexed citations
4.
Chiarella, Paula, et al.. (2008). Therapeutic Anti-Tumor Vaccines: From Tumor Inhibition to Enhancement. SHILAP Revista de lepidopterología. 2. 237–45. 9 indexed citations
5.
Chiarella, Paula, Marisa Vulcano, Mónica Vermeulen, et al.. (2007). Anti-inflammatory pretreatment enables an efficient dendritic cell-based immunotherapy against established tumors. Cancer Immunology Immunotherapy. 57(5). 701–718. 25 indexed citations
6.
Chiarella, Paula, et al.. (2007). Reversión del eclipse inmunológico y vacunación terapéutica contra el cáncer en un modelo experimental. Conicet. 67(1). 44–48. 1 indexed citations
7.
Chiarella, Paula, et al.. (2007). [Systemic inflammation and experimental cancer in a murine model].. PubMed. 67(5). 469–74. 2 indexed citations
8.
Bustuoabad, Oscar D., Roberto P. Meiss, Sonia Gómez, et al.. (2006). Compensatory renal growth protects mice against Shiga toxin 2-induced toxicity. Pediatric Nephrology. 21(8). 1082–1092. 1 indexed citations
9.
Ruggiero, Raúl A. & Oscar D. Bustuoabad. (2006). The biological sense of cancer: a hypothesis. Theoretical Biology and Medical Modelling. 3(1). 43–43. 17 indexed citations
10.
Pasqualini, Christiane Dosne, Raúl A. Ruggiero, Oscar D. Bustuoabad, Irene Nepomnaschy, & Isabel Piazzón. (2005). Experimental Onco-Immunology Revisited. Current Cancer Therapy Reviews. 1(3). 289–298. 3 indexed citations
11.
Franco, María Clara, et al.. (1996). A serum-mediated mechanism for concomitant resistance shared by immunogenic and non-immunogenic murine tumours. British Journal of Cancer. 74(2). 178–186. 32 indexed citations
12.
Bonfil, R. Daniel, Antònia Vinyals, Oscar D. Bustuoabad, et al.. (1994). Stimulation of angiogenesis as an explanation of matrigel‐enhanced tumorigenicity. International Journal of Cancer. 58(2). 233–239. 42 indexed citations
13.
Bonfil, R. Daniel, Eduardo Farias, Alberto Lazarowski, et al.. (1992). Expression of gelatinise/type IV collagenase in tumor necrosis correlates with cell detachment and tumor invasion. Clinical & Experimental Metastasis. 10(3). 211–220. 19 indexed citations
14.
Ruggiero, Raúl A., Oscar D. Bustuoabad, Paula Cramer, R. Daniel Bonfil, & Christiane Dosne Pasqualini. (1990). Correlation between seric antitumor activity and concomitant resistance in mice bearing nonimmunogenic tumors.. PubMed. 50(22). 7159–65. 23 indexed citations
15.
Bonfil, R. Daniel, Raúl A. Ruggiero, Oscar D. Bustuoabad, Roberto P. Meiss, & Christiane Dosne Pasqualini. (1988). Role of concomitant resistance in the development of murine lung metastases. International Journal of Cancer. 41(3). 415–422. 22 indexed citations
16.
Bonfil, R. Daniel, et al.. (1988). Tumor necrosis can facilitate the appearance of metastases. Clinical & Experimental Metastasis. 6(2). 121–129. 51 indexed citations
17.
Leirós, Claudia Pérez, Leonor Sterin‐Borda, Patricío M. Cossio, Oscar D. Bustuoabad, & Enri Borda. (1986). Potential role of mononuclear cells infiltration on the autoimmune myocardial dysfunction.. PubMed. 63(3). 648–55. 14 indexed citations
18.
Ruggiero, Raúl A., Oscar D. Bustuoabad, R. Daniel Bonfil, Roberto P. Meiss, & Christiane Dosne Pasqualini. (1985). “Concomitant immunity” in murine tumours of non-detectable immunogenicity. British Journal of Cancer. 51(1). 37–48. 58 indexed citations
19.
Mazzolli, Alicia B., et al.. (1985). Macrophages and Tumor Growth. II. Cell Kinetics at the Site of Allogeneic Tumor Growth. Cancer Investigation. 3(1). 7–13. 3 indexed citations
20.
Bustuoabad, Oscar D., et al.. (1977). Different sensitivity to lithium ion during the segmentation of Bufo arenarum eggs.. PubMed. 271–82. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026